Diprovocim-1
Diprovocim-1 is a potent TLR1/2 agonist that stimulates TNF-α release in THP-1 cells and enhances antigen-specific IgG1 production in vivo. It acts as an effective vaccine adjuvant and synergizes with anti-PD-L1 therapy to promote cytotoxic T cell activity, reducing tumor growth in melanoma models.
Product Specifications
CAS Number
2170867-89-5
Field of Research
Cell Biology, Immunology & Inflammation, Signal Transduction
Purity
99.64% (May vary between batches)
Smiles
N (C (=O) [C@H]1[C@H] (C (N[C@@H]2[C@H] (C2) C3=CC=CC=C3) =O) CN (C (=O) C4=CC=C (C (=O) N5C[C@@H] (C (N[C@@H]6[C@H] (C6) C7=CC=CC=C7) =O) [C@H] (C (N[C@@H]8[C@H] (C8) C9=CC=CC=C9) =O) C5) C=C4) C1) [C@@H]%10[C@H] (C%10) C%11=CC=CC=C%11
Molecular Formula
C56H56N6O6
Molecular Weight
909.10
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV649946 1.0 µg DNA
SIGLEC1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details MBS1570588-03 5x 1 mg
Anti-Human PILRA/PILRalpha Antibody (SAA1628)
Sign In for Pricing
View Details 